Pyridostigmine Bromide · oral tablet
Misc.
Approved uses
Myasthenia gravis
Conventional 60 mg tablets: average ten a day, spaced to provide maximum relief, adjusted to response. Timespan 180 mg tablets: one to three, once or twice daily, usually sufficient, at least 6 hours apart.
Ocular myasthenia is what an optometrist meets first: ptosis and variable diplopia, worse through the day
Contraindications
Mechanical intestinal or urinary obstruction.
60 mg tablets, bottles of 100; 180 mg extended-release tablets, bottles of 30; oral solution 60 mg per 5 mL, 473 mL bottle
Pyridostigmine is an orally active cholinesterase inhibitor. It inhibits the destruction of acetylcholine by cholinesterase and thereby permits freer transmission of nerve impulses across the neuromuscular junction.
Warnings & Precautions
- Cholinergic crisis: failure to show clinical improvement may reflect underdosage, but it can also be indicative of overdosage. Overdosage may result in cholinergic crisis, with increasing muscle weakness that, through involvement of the muscles of respiration, may lead to death. The diagnosis of cholinergic crisis calls for the prompt withdrawal of all drugs of this type, and the immediate use of atropine is also recommended.
- Myasthenic crisis: myasthenic crisis due to an increase in the severity of the disease is also accompanied by extreme muscle weakness, and thus may be difficult to distinguish from cholinergic crisis on a symptomatic basis. Increasing the dose in cholinergic crisis or a refractory or insensitive state could have grave consequences. Differential diagnosis may require Tensilon (edrophonium chloride) as well as clinical judgment; myasthenic crisis suggests the need for more intensive anticholinesterase therapy.
- Masking of overdosage: atropine can counter muscarinic side effects, but by masking signs of overdosage it can lead to cholinergic crisis.
- Particular caution: use particular caution when giving pyridostigmine to patients with bronchial asthma.
- Precaution: pyridostigmine is mainly excreted unchanged by the kidney, so lower doses may be required in patients with renal disease, titrated to effect.
Common Side Effects
Most side effects reflect overdosage. Muscarinic effects include nausea, vomiting, diarrhea, abdominal cramps, increased peristalsis, increased salivation and bronchial secretions, miosis and diaphoresis; nicotinic effects are chiefly muscle cramps, fasciculation and weakness. The bromide can cause an occasional skin rash.
Pregnancy: Safety during pregnancy has not been established; weigh the potential benefits against the possible hazards to mother and child.
Lactation: Safety during lactation has not been established.
Safety and effectiveness in pediatric patients have not been established.